(Q45244765)

11 December 2017

title

Zebrafish assays as early safety pharmacology screens: paradigm shift or red herring? (English)

1 reference

11 December 2017

0 references

1 reference

1 reference

3

1 reference

11 December 2017

William S Redfern

1

1 reference

11 December 2017

Gareth Waldron

2

1 reference

11 December 2017

Paul Butler

4

1 reference

11 December 2017

Mark Holbrook

5

1 reference

11 December 2017

Rob Wallis

6

1 reference

11 December 2017

Jean-Pierre Valentin

7

1 reference

11 December 2017

publication date

3 June 2008

1 reference

Journal of Pharmacological and Toxicological Methods

11 December 2017

published in

1 reference

11 December 2017

volume

58

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

110-117

1 reference

Blocking expression of AHR2 and ARNT1 in zebrafish larvae protects against cardiac toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

High-throughput behavioral screening method for detecting auditory response defects in zebrafish.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Visual discrimination learning in zebrafish (Danio rerio).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Drug discovery in jeopardy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

High-throughput in vitro profiling assays: lessons learnt from experiences at Novartis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Antipsychotics produce locomotor impairment in larval zebrafish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Report of the Validation and Technology Transfer Committee of the Johns Hopkins Center for Alternatives to Animal Testing. Framework for validation and implementation of in vitro toxicity tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Zebrafish as a pharmacological tool: the how, why and when

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

A place for high-throughput electrophysiology in cardiac safety: screening hERG cell lines and novel compounds with the ion works HTTM system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Can optical recordings of membrane potential be used to screen for drug-induced action potential prolongation in single cardiac myocytes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Morpholino oligos: making sense of antisense?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Acute renal failure in zebrafish: a novel system to study a complex disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Toward an evidence-based toxicology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Ontogeny of the gut motility control system in zebrafish Danio rerio embryos and larvae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Inner ear hair cells produced in vitro by a mesenchymal-to-epithelial transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Zebrafish: an emerging model system for human disease and drug discovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Can the pharmaceutical industry reduce attrition rates?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

The rat retinal ganglion cell in culture: an accessible CNS neurone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Electrophysiological characteristic of corticoaccumbens synapses in rat mesolimbic system reconstructed using organotypic slice cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Evaluation of the cytotoxicity of selected systemic and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Evaluation of zebrafish embryos as a model for assessing inhibition of hERG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Behavioral genetic approaches to visual system development and function in zebrafish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

The zebrafish as a model system for assessing the reinforcing properties of drugs of abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Automated electrophysiology in drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Acute alcohol blocks neurosteroid modulation of synaptic transmission and long-term potentiation in the rat hippocampal slice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Spectrum of effects detected in the rat functional observational battery following oral administration of non-CNS targeted compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Isolated heart perfusion according to Langendorff---still viable in the new millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

The use of zebrafish for assessing ototoxic and otoprotective agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Electrophysiological recording of re-aggregating brain cell cultures on multi-electrode arrays to detect acute neurotoxic effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

The application of in vitro methods to safety pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

The genetic basis of cardiac function: dissection by zebrafish (Danio rerio) screens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

Patch clamping by numbers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

In vivo drug discovery in the zebrafish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.05.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VASCN.2008.05.006

1 reference

11 December 2017

1 reference